Sundeep Agrawal - 06 Aug 2026 Form 4 Insider Report for BlossomHill Therapeutics, Inc. (BLSM)

Reporting relationship: Director
Issuer ticker: BLSM
Reported as of: 06 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Aug 2026, 18:29:03 UTC
Prior SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Vincent Liptak, Attorney-in-Fact

Key filing fact

Sundeep Agrawal filed Form 4 for BlossomHill Therapeutics, Inc. (BLSM) on 10 Aug 2026.

Key facts

This page summarizes Sundeep Agrawal's Form 4 filing for BlossomHill Therapeutics, Inc. (BLSM).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Aug 2026, 18:29.

Change

Previous filing in this sequence was filed on 03 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001840599 Primary reporting owner

Agrawal Sundeep

Relationship: Director
Address: C/O BLOSSOMHILL THERAPEUTICS, INC., 10255 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO
Signature: /s/ Vincent Liptak, Attorney-in-Fact
Signature date: 10 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLSM transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +578,524
Change %
Price
Shares after: 578,524
Date: 10 Aug 2026
Ownership: By Brahma BlossomHill Partners, LLC
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BLSM transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value
Shares: +23,904
Change %
Price: $0.000000^*
Shares after: 23,904
Date: 06 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,904
Exercise price: $16.00
Footnotes: F3

BLSM transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares: -578,524
Change %: -100%
Price
Shares after: 0
Date: 10 Aug 2026
Ownership: By Brahma BlossomHill Partners, LLC
Underlying class: Common Stock
Underlying amount: 578,524
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each share of Series B Preferred Stock (the "Preferred Stock") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date.

Footnote F2

The securities are held of record by Brahma BlossomHill Partners, LLC ("Brahma Partners"). The Reporting Person is the founder and managing partner of Brahma Capital, LLC, which manages Brahma Partners, and may be deemed to have sole voting and/or investment power over the securities held by Brahma Partners. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Footnote F3

1/36th of the shares subject to the option shall vest in equal monthly installments over a three year period following August 6, 2026.